首页> 外国专利> LIQUIDIC FORMULATION FOR ORAL ADMINISTRAION COMPRISING AMBROXOL, LEVODROPROPIZINE AND BUFFER, AND METHOD FOR PREPARING THE SAME

LIQUIDIC FORMULATION FOR ORAL ADMINISTRAION COMPRISING AMBROXOL, LEVODROPROPIZINE AND BUFFER, AND METHOD FOR PREPARING THE SAME

机译:包含氨溴索,左丙泊嗪和缓冲剂的口服给药的液体制剂及其制备方法

摘要

PURPOSE: An oral liquid medicine is provided to prevent the change of quality by changes according to time since the storage stability is excellent, and to have high drug compliance, thereby being used as a medicine for acute and chronic cough. CONSTITUTION: An oral liquid medicine comprises Ambroxol or pharmaceutically acceptable salt thereof, Levodropropizine or pharmaceutically acceptable salt thereof, and a buffer in the aqueous medium and has a pH of 4.5-5.5. A manufacturing method of the oral liquid medicine comprises: a step of dissolving the pharmaceutically acceptable diluting agent in the aqueous medium; a step of adjusting the pH of the mixture as 4.5 to 5.5 using the buffer; a step of adding the Ambroxol or pharmaceutically acceptable salt thereof, the Levodropropizine or pharmaceutically acceptable salt thereof to the mixture and dissolving; and a step of adding the aqueous medium to the mixture. [Reference numerals] (AA) Stress condition 4 weeks; (BB) Stress condition 2 weeks
机译:目的:提供一种口服液药物,因为其储存稳定性极好,可防止随时间变化而导致质量变化,并且具有很高的药物依从性,因此被用作急,慢性咳嗽的药物。组成:一种口服液体药物,其包含氨溴索或其药学上可接受的盐,左旋ropropizine或其药学上可接受的盐,以及在水性介质中的缓冲液,其pH值为4.5-5.5。口服液体药物的制造方法包括:将药学上可接受的稀释剂溶解在水性介质中的步骤;使用缓冲液将混合物的pH调节至4.5至5.5的步骤;向混合物中加入氨溴索或其药学上可接受的盐,左氧哌罗哌嗪或其药学上可接受的盐并将其溶解的步骤;将水介质添加到混合物中的步骤。 [参考数字](AA)应激状态4周; (BB)压力状况2周

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号